All terms in GO
| Label | Id | Description |
|---|---|---|
| Notch signaling pathway involved in negative regulation of venous endothelial cell fate commitment | GO_2000796 | [Any Notch signaling pathway that is involved in negative regulation of venous endothelial cell fate commitment.] |
| Notch signaling pathway | GO_0007219 | [A series of molecular signals initiated by the binding of an extracellular ligand to the receptor Notch on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.] |
| 1-nitro-1,2-dihydro-1,3,5-triazine hydrolase activity | GO_0034565 | [Catalysis of the reaction: 1-nitro-1,2-dihydro-1,3,5-triazine + 2 H2O = 1-nitro-1,3,5-triazinane-2,4-diol.] |
| cell proliferation involved in heart valve development | GO_2000793 | [Any cell proliferation that is involved in heart valve development.] |
| heart valve development | GO_0003170 | [The progression of a heart valve over time, from its formation to the mature structure. A heart valve is a structure that restricts the flow of blood to different regions of the heart and forms from an endocardial cushion.] |
| GO_0034566 | GO_0034566 | |
| bisphenol A hydroxylase A activity | GO_0034560 | [Catalysis of the reaction: bisphenol A + NADH + H+ + O2 = 2,2-bis(4-hydroxyphenyl)-1-propanol + NAD+ + H2O.] |
| positive regulation of amniotic stem cell differentiation | GO_2000799 | [Any process that activates or increases the frequency, rate or extent of amniotic stem cell differentiation.] |
| positive regulation of mesenchymal stem cell differentiation | GO_2000741 | [Any process that activates or increases the frequency, rate or extent of mesenchymal stem cell differentiation.] |
| regulation of amniotic stem cell differentiation | GO_2000797 | [Any process that modulates the frequency, rate or extent of amniotic stem cell differentiation.] |
| amniotic stem cell differentiation | GO_0097086 | [The process whereby a relatively unspecialized cell acquires specialized features of an amniotic stem cell. An amniotic stem cell is a mesenchymal stem cell extracted from amniotic fluid. Amniotic stem cells are able to differentiate into various tissue types such as skin, cartilage, cardiac tissue, nerves, muscle, and bone.] |
| monodemethylisoproturon dehydrogenase activity | GO_0034569 | [Catalysis of the reaction: monodemethylisoproturon + H2O = hydroxymonodemethylisoproturon + 2 H+ + 2 e-.] |
| regulation of mesenchymal stem cell differentiation | GO_2000739 | [Any process that modulates the frequency, rate or extent of mesenchymal stem cell differentiation.] |
| negative regulation of amniotic stem cell differentiation | GO_2000798 | [Any process that stops, prevents or reduces the frequency, rate or extent of amniotic stem cell differentiation.] |
| negative regulation of mesenchymal stem cell differentiation | GO_2000740 | [Any process that stops, prevents or reduces the frequency, rate or extent of mesenchymal stem cell differentiation.] |
| U4 snRNA 3'-end processing | GO_0034475 | [Any process involved in forming the mature 3' end of a U4 snRNA molecule.] |
| snRNA 3'-end processing | GO_0034472 | [Any process involved in forming the mature 3' end of an snRNA molecule.] |
| U5 snRNA 3'-end processing | GO_0034476 | [Any process involved in forming the mature 3' end of a U5 snRNA molecule.] |
| U1 snRNA 3'-end processing | GO_0034473 | [Any process involved in forming the mature 3' end of a U1 snRNA molecule.] |
| U2 snRNA 3'-end processing | GO_0034474 | [Any process involved in forming the mature 3' end of a U2 snRNA molecule.] |